Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprine

Arthritis and Rheumatism

Volumn 39, Issue 6, 1996, Pages 1016-1020

  Blanco, Ricardo ^a   Martínez Taboada, Victor M ^b   González Gay, Miguel A ^a   Armona, Jose ^b   Fernández Sueiro, Jose L ^b   Gonzaléz Vela, M Carmen ^b   Rodríguez Valverde, Vicente ^b  

^a HOSPITAL XERAL CALDE   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; CHLOROQUINE; GOLD SALT; METHOTREXATE; PENICILLAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; FEVER; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; LEUKOCYTOSIS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ACUTE DISEASE; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AZATHIOPRINE; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HUMANS; LEUKOCYTOSIS; MALE; METHOTREXATE; RETROSPECTIVE STUDIES; TIME FACTORS; VASCULITIS, ALLERGIC CUTANEOUS;

EID: 0029894748     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390619     Document Type: Article

References (19)

1. McCarty DJ: Personal experience in the treatment of seropositive rheumatoid arthritis with drug used in combination. Semin Arthritis Rheum 23:42-49, 1993
2. Wilke WS, Clough JD: Therapy for rheumatoid arthritis: combinations of disease-modifying drugs and new paradigms of treatment. Semin Arthritis Rheum 21:21-34, 1991
3. Willkens RF, Urowitz MB, Stablein DM, McKendry RJR Jr, Berger RG, Box JH, Fiechtner JJ, Fudman EJ, Hudson NP, Marks CR, Brooks R, Rooney TW, Rubin BR, Schmid FR, Segal AM, Thomas JW, Golstein AG, Yunus MB, Wortmann RL, Sherrer YRS: Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 35:849-856, 1992
4. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
5. Singh G, Fries JF, Spitz P, Williams CA: Toxic effects of azathioprine in rheumatoid arthritis: a national post-marketing perspective. Arthritis Rheum 32:837-843, 1989
6. Kissel JT, Levy RJ, Mendell JR, Griggs RC: Azathioprine toxicity in neuromuscular diseases. Neurology 36:35-39, 1986
7. Jeurissen MEC, Boerbons AM Th, van de Putte LBA, Kruijsen MWM: Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis. Ann Rheum Dis 49:25-27, 1990
8. Saway PA, Heck LW, Bonner JR, Kirklin JK: Azathioprine hypersensitivity: case report and review of the literature. Am J Med 84:960-964, 1988
9. Bergman SM, Krane NK, Leonard G, Soto-Aguilar MC, Wallin JD: Azathioprine and hypersensitivity vasculitis. Ann Intern Med 109:83-84, 1988
10. Rosenthal E: Azathioprine shock. Postgrad Med J 62:677-678, 1986
11. Keystone EC, Shabas R: Hypotension with oliguria: a side-effect of azathioprine (letter). Arthritis Rheum 24:1453-1454, 1981
12. Trotta F, Menegale G, Fiocchi O: Azathioprine-induced hypotension with oliguria (letter). Arthritis Rheum 25:1388-1389, 1982
13. Cunningham T, Barraclough D, Muirden K: Azathioprine-induced shock. BMJ 283:623-624, 1982
14. Navarro M, Pedragosa R, Lafuerza A, Rubio D, Huguet P: Leukocytoclastic vasculitis after high-dose methotrexate. Ann Intern Med 105:471-472, 1986
15. Davis M, Eddleston A, Williams R: Hypersensitivity and jaundice due to azathioprine. Postgrad Med J 56:274-275, 1980
16. Watts G, Corston R: Hypersensitivity to azathioprine in myasthenia gravis. Postgrad Med J 60:326-363, 1984
17. Lennard L, Van Loon JA, Weinshilboum RM: Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyl-transferase genetic polymorphism. Clin Pharmacol Ther 46:149-154, 1989
18. Kerstens PJSM, Stolk JN, De Abreu RA, Lambooy LHJ, van de Putte LBA, Boerbooms AAMT: Azathioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis. Arthritis Rheum 38:142-145, 1995
19. Balis FM, Holcenberg JS, Zimm S, Tubergen D, Collins JM, Murphy RF, Gilchrist GS, Hammond D, Poplack DG: The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clin Pharmacol Ther 41:384-387, 1987